Stocklytics Platform
Asset logo for symbol DHR
Danaher
DHR
55
$254.48arrow_drop_down0.88%-$2.28
S&P500

Performance History

Chart placeholder
Key Stats
Open$255.87
Prev. Close$256.76
EPS5.46
Dividend$1.05
Next Earnings DateOct 25, 2024
Dividend Yield %0.42%
Market Cap$188.84B
PE Ratio46.56
LOWHIGH
Day Range254.00
257.41
52 Week Range182.09
269.10
Ratios
P/B Ratio3.32
Revenue$14.03B
Operating M. %23.09%
Earnings$4.22B
Earnings Growth %-41.45%
EBITDA Margin %52.85%
ROE %7.76%
EPS5.46

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Correlated Companies

Price$900.52
Perf. (24h)
arrow_drop_up1.17%$10.41
Market Cap$840.04B
Price$484.42
Perf. (24h)
arrow_drop_down1.13%-$5.56
Market Cap$451.00B
Price$146.98
Perf. (24h)
arrow_drop_down1.43%-$2.14
Market Cap$357.99B
Price$132.77
Perf. (24h)
arrow_drop_down0.14%-$0.19
Market Cap$331.08B

About Danaher (DHR)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, municipal, industrial, and natural resource applications. It also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. The company was founded in 1969 and is headquartered in Washington, the District of Columbia.

Sector
Healthcare
Industry
Diagnostics & Research
CEO
Mr. Rainer M. Blair
Headquarters
Washington
Employees
79000
Exchange
NYSE
add Danaher to watchlist

Keep an eye on Danaher

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is Danaher's (DHR) price per share?

The current price per share for Danaher (DHR) is $254.48. The stock has seen a price change of -$2.28 recently, indicating a -0.89% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for Danaher (DHR)?

For Danaher (DHR), the 52-week high is $269.11, which is 5.75% from the current price. The 52-week low is $182.09, the current price is 39.76% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is Danaher (DHR) a growth stock?

Danaher (DHR) has shown an average price growth of 0.41% over the past three years. It has received a score of 53 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Danaher as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is Danaher (DHR) stock price performance year to date (YTD)?

As of the latest data, Danaher (DHR) has a year-to-date price change of 8.39%. Over the past month, the stock has experienced a price change of -3.16%. Over the last three months, the change has been 2.7%. Over the past six months, the figure is 9.97%. Looking at a longer horizon, the five-year price change stands at 101.94%.

help
Is Danaher (DHR) a profitable company?

Danaher (DHR) has a net income of $4.22B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 23.09% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $14.03B, although specific revenue growth data is currently not available. The gross profit is $14.03B. Operating income is noted at $5.2B. Furthermore, the EBITDA is $7.34B.

help
What is the market capitalization of Danaher (DHR)?

Danaher (DHR) has a market capitalization of $188.85B. The average daily trading volume is 4.01M, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level